Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hagan

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Regulatory Peptides|July 2, 1993
Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonistsR M Hagan, I J Beresford, J Stables, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 18, 2000
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockadeM M Hagan, P A Rushing, L M Pritchard, et al.
European Journal of Pharmacology|January 16, 1995
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.
Plos One|May 23, 2014
Extending the Schizosaccharomyces pombe molecular genetic toolboxDorota Fennessy, Agnes Grallert, Andrea Krapp, et al.
Journal of Medicinal Chemistry|July 10, 1992
Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptorA B McElroy, S P Clegg, M J Deal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 1998
Association between coronary heart disease and cancers of the breast, prostate, and colonA I Neugut, D J Rosenberg, H Ahsan, et al.
Infection and Immunity|December 19, 2018
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic AntigensCysha E Hall, Lisa M Hagan, Elke Bergmann-Leitner, et al.
Current Biology : CB|December 23, 1999
The COP9/signalosome complex is conserved in fission yeast and has a role in S phaseK E Mundt, J Porte, J M Murray, et al.
Brain Research|June 19, 2001
The effect of feeding on cerebrospinal fluid corticotropin-releasing hormone levels in humansJ W Kasckow, M Hagan, J J Mulchahey, et al.
British Journal of Pharmacology|January 22, 2009
BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headacheK A Maubach, R J Davis, D E Clark, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Regulatory Peptides|July 2, 1993
Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonistsR M Hagan, I J Beresford, J Stables, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 18, 2000
Long-term orexigenic effects of AgRP-(83---132) involve mechanisms other than melanocortin receptor blockadeM M Hagan, P A Rushing, L M Pritchard, et al.
European Journal of Pharmacology|January 16, 1995
GR159897, a potent non-peptide antagonist at tachykinin NK2 receptorsI J Beresford, R L Sheldrick, D I Ball, et al.
Plos One|May 23, 2014
Extending the Schizosaccharomyces pombe molecular genetic toolboxDorota Fennessy, Agnes Grallert, Andrea Krapp, et al.
Journal of Medicinal Chemistry|July 10, 1992
Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptorA B McElroy, S P Clegg, M J Deal, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 31, 1998
Association between coronary heart disease and cancers of the breast, prostate, and colonA I Neugut, D J Rosenberg, H Ahsan, et al.
Infection and Immunity|December 19, 2018
Mosquito Bite-Induced Controlled Human Malaria Infection with Plasmodium vivax or P. falciparum Generates Immune Responses to Homologous and Heterologous Preerythrocytic and Erythrocytic AntigensCysha E Hall, Lisa M Hagan, Elke Bergmann-Leitner, et al.
Current Biology : CB|December 23, 1999
The COP9/signalosome complex is conserved in fission yeast and has a role in S phaseK E Mundt, J Porte, J M Murray, et al.
Brain Research|June 19, 2001
The effect of feeding on cerebrospinal fluid corticotropin-releasing hormone levels in humansJ W Kasckow, M Hagan, J J Mulchahey, et al.
British Journal of Pharmacology|January 22, 2009
BGC20-1531, a novel, potent and selective prostanoid EP receptor antagonist: a putative new treatment for migraine headacheK A Maubach, R J Davis, D E Clark, et al.
Pageof 28